The Index · Crosslinked hyaluronate polymer

Sodium Hyaluronate Crosspolymer-7

Crosslinked HA (sodium trimetaphosphate); in CIR’s first Draft Report on six sodium hyaluronate crosspolymers for the Oct 2026 Panel.

EmergingCIR Draft Report (11 Sep 2026); conclusion pending Oct Panel.

Written byTheSkindex Desk

Reviewed byNot yet reviewed

Last updated5 Oct 2026

Sources2 cited

Sodium Hyaluronate Crosspolymer-7 is hyaluronate crosslinked with sodium trimetaphosphate. It is one of six ingredients in CIR’s September 2026 Draft Report for the 5–6 October 2026 Expert Panel meeting [1].

What it does

Crosslinking builds a 3D humectant network distinct from linear hyaluronic acid. Dictionary functions are skin-conditioning / humectant [1].

The evidence

Evidence grade emerging: no CIR conclusion yet. Discussion and Conclusion in the Draft Report are still to be developed [1] [2].

Safety

Review in progress.

Evidence by claim

Graded separately; the entry grade is the best-supported claim

Humectant / skin-conditioning crosslinked HA network[1]

Emerging

Safety & limits

Source and region, always

all — CIR Draft Report under review; no final conclusion yet.[1] CA US EU UK

Sources · 2

Numbered as cited in the text

[1]Cosmetic Ingredient Review. Safety Assessment of Sodium Hyaluronate Crosspolymers (Draft Report). CIR (2026)regulator
[2]Cosmetic Ingredient Review. Expert Panel Meeting Admin — October 5–6, 2026. CIR (2026)regulator

Revision history

18 Sept 2026Drafted by botTheSkindex Desk